United States · Series A startup

Who invested in MicroByre

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$15Mraised across 1 round since 2022, from 1 source

Latest round
Series A, $15MJan 2022
Investors
3
See who backed them

The rounds

  1. Jan 2022
    Series A$15M

    Source recordedSEC filing: $11M sold, first sale Jan 2022

Founders and team

From the SEC filings it signed: 2 on the team.

  • Jeffrey AndersonExecutive Officer, Directori
  • Sarah RichardsonExecutive Officer, Directori

On the board, as filediMatthew NordanRik Wehbring

Everyone who backed them

Lowercarbon CapitalVC firm1round
Safar PartnersVC firm1round
MCJVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists MicroByre as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Impact Science VenturesVC firmPer its own site

Quick answers about MicroByre

Who invested in MicroByre?

MicroByre's investors include Lowercarbon Capital, Safar Partners and MCJ.

How much has MicroByre raised?

MicroByre has raised $15M across 1 round since 2022.

When did MicroByre last raise?

MicroByre's most recent round was a Series A of $15M in Jan 2022.

What was MicroByre's biggest round?

Its most recent round, $15M in Jan 2022, is also its largest on record.

Who backed MicroByre first?

MicroByre's first round on record, in Jan 2022, was backed by Lowercarbon Capital, Safar Partners and MCJ.

What stage is MicroByre at?

MicroByre's latest named round is a Series A, in Jan 2022.

Where is MicroByre based?

MicroByre is based in the United States.

Companies like MicroByre

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.